NEW YORK--(BUSINESS WIRE)--March 22, 2006--IRX Therapeutics, a privately-held company dedicated to the development and commercialization of novel drugs for the treatment of cancer and viral diseases, today announced that it has raised $12.5 million through a convertible note offering.
